Joshua Mugford

Joshua Mugford is an accomplished scientist with extensive experience in drug discovery and biology, currently serving as Drug Maker in Residence at Curie.Bio since October 2023. Prior to this role, Joshua held various positions at Zentalis Pharmaceuticals, including Director and Associate Director of Discovery Biology from February 2021 to October 2023. Previous roles at Bristol Myers Squibb and Celgene involved senior scientific responsibilities focused on epigenetics and oncology. Joshua’s career began with a post-doctoral fellowship at the University of North Carolina at Chapel Hill, followed by graduate studies at Harvard University, where a PhD in Biology - Developmental Genetics was earned. Educational background also includes a B.S. in Biological Sciences from Carnegie Mellon University. Research expertise spans epigenomic engineering, therapeutic development, and cross-functional collaboration in life sciences.